Cancer-Plex (33 analytes)
Protavio’s Cancer-Plex panel quantifies 33 protein markers of various types of cancer, ranging from melanoma and lung cancer, to lymphomas and breast cancer. It provides a reliable platform of several biomarkers that are present in the blood serum or urine of patients and may be used for the diagnosis of early-stage cancer, preventing cancer progression and metastasis.
ALB, AREG, BLC (CXCL13, BCA1), CDH11, COMP (TSP5, EDM1), CRP (PTX1), EGVEGF (PROK1), FST, GAL3, GDF15 (PTGFβ), GROA (CXCL1,) IFNγ, IL10, IL6 (IFNβ2), IL7 (PBGF), IL8 (CXCL8), MIP3α (CCL20), MMP9, MYOF (FER1L3), NRG1 (HRG1), PARC (CCL18), S100A8 (MIF), SAA1 (PIG4), SDF1α (CXCL12), ST2 (IL33R, IL1RL1), TFF3 (HITF), TGFβ1, TIMP1 (EPO), TNFα, TRAIL (TNF10, Apo2L), TSP2, TWEAK (TNF12), ZG16.
Sample types that can be processed include blood, serum, urine, CSF, BALF, tears, cell culture supernatants, tissue cryo-sections and cell lysates.
Samples can be delivered in micro centrifuge tubes or 96-well micro titre plates.
Delivery should be arranged in dry ice between Mon-Wed to ensure adequate receipt of samples.